WFSBP Programme 2015

27 / 112

25
WFSBP 2015
Monday, 15 June 2015 | Scientific Programme
S-04-003
Imaging and clinical intervention in metamphetamine ad-
diction
Hamed Ekhtiari, Iran
S-04-004
Clinical intervention in drinking-smoking co-morbidity
Bo Söderpalm, Sweden
A. deBejczy, E. Lof, L. Walther, A. Isaksson, J. Guterstam,
A. Hammarberg, G. Asanovska, J. Franck
T4: Anxiety Disorders: Basic / Clinical
S-05 Symposium
08:30–10:00 MC 2 Room
Sex differences in the neurobiology of fear and anxiety:
A translational approach
Chair: Mohammed Milad, USA
Co-Chair: Oliver Wolf, Germany
S-05-001
Sex-dependent vulnerability and response of brain circuits
in affective disorders and treatment: Evidence from pre-
clinical models
Ioannis Sotiropoulos, Portugal
S-05-002
Sex differences: Gonadal hormone modulation of fear ex-
tinction
Lisa Maeng, USA
S-05-003
Stress and emotional learning in humans: Does sex make
a difference?
Oliver Wolf, Germany
C. Merz
S-05-004
Influence of estrogen on the neural correlates of fear ex-
tinction across species
Kelimer Lebron-Milad, USA
T10: Depression: Basic / Clinical
S-52 Symposium
11:00–12:30 Mitropoulos Hall
Identifying biomarkers of treatment outcome in depres-
sion: Canadian network for biomarker integration in de-
pression
Chair: Sidney Kennedy, Canada
Co-Chair: Gregor Hasler, Switzerland
S-52-001
Biomarkers and the future of treatment in depression
Madhukar Trivedi, USA
S-52-002
Discovering endophenotypes in major depression
Gregor Hasler, Switzerland
S-52-003
Genese: Pharmacogenetic response to antidepressant
treatment in the general population treated for depression
Nicolas Ramoz, France
Y. Le Strat, P. Courtet, P. Gorwood
S-52-004
CANBIND–Update on the progress so far
Sidney Kennedy, Canada
T1: Addictive Disorders
S-38 Symposium
11:00–12:30 Skalkotas Hall
New challenges in psychoactive substances and addic-
tions treatments
Chair: Amine Benyamina, France
Co-Chair: Franco Tagliaro, Italy
S-38-001
Clinical efficacy of high dose of baclofen in reducing alcohol
consumption
Philippe Jaury, France
S-38-002
Impact of chronic cannabinoid adolescent exposure on
prefrontal structure and function
Therese Jay, France
G. Le Pen, M.-O. Krebs, J. Renard
S-38-003
New challenges for forensic toxicology from the “New Psy-
choactive Substances”
Franco Tagliaro, Italy
S-38-004
Acute human effects of synthetic cannabinoids: How are
they related to cannabinoid receptor ligand properties?
David Gorelick, USA
T1: Addictive Disorders
S-08 Symposium
11:00–12:30 MC 2 Room
Behavioral addictions: Diagnosis, co-morbidity and
neurobiology
Chair: Aviv Weinstein, Israel
Co-Chair: Marc Potenza, USA
S-08-001
Hypersexuality: Obsession or addiction?
Florence Thibaut, France
S-08-002
A personal status, legal, economic and psychological com-
parison of types of adult male gamblers
Pinhas Dannon, Israel